Clinical Trial Update: Salivary Cortisol As a Biomarker in Patients with Temporomandibular Disorder

View source ↗

Summary

An entry for a clinical trial evaluating salivary cortisol as a biomarker in patients with Temporomandibular Joint Disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Temporomandibular Joint Disorder

Snippet

Sponsor: University of Coimbra | Conditions: Temporomandibular Joint Disorder | Status: RECRUITING